| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 6 | 
| NetGPI | no | yes: 0, no: 6 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0016020 | membrane | 2 | 5 | 
| GO:0110165 | cellular anatomical entity | 1 | 5 | 
Related structures:
AlphaFold database: Q4QIU7
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 7 | 
| GO:0006778 | porphyrin-containing compound metabolic process | 5 | 7 | 
| GO:0006779 | porphyrin-containing compound biosynthetic process | 6 | 7 | 
| GO:0006782 | protoporphyrinogen IX biosynthetic process | 7 | 7 | 
| GO:0006783 | heme biosynthetic process | 4 | 2 | 
| GO:0006807 | nitrogen compound metabolic process | 2 | 7 | 
| GO:0008152 | metabolic process | 1 | 7 | 
| GO:0009058 | biosynthetic process | 2 | 7 | 
| GO:0009987 | cellular process | 1 | 7 | 
| GO:0018130 | heterocycle biosynthetic process | 4 | 7 | 
| GO:0019438 | aromatic compound biosynthetic process | 4 | 7 | 
| GO:0033013 | tetrapyrrole metabolic process | 4 | 7 | 
| GO:0033014 | tetrapyrrole biosynthetic process | 5 | 7 | 
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 7 | 
| GO:0042168 | heme metabolic process | 3 | 2 | 
| GO:0042440 | pigment metabolic process | 2 | 2 | 
| GO:0044237 | cellular metabolic process | 2 | 7 | 
| GO:0044249 | cellular biosynthetic process | 3 | 7 | 
| GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 7 | 
| GO:0046148 | pigment biosynthetic process | 3 | 2 | 
| GO:0046483 | heterocycle metabolic process | 3 | 7 | 
| GO:0046501 | protoporphyrinogen IX metabolic process | 6 | 7 | 
| GO:0071704 | organic substance metabolic process | 2 | 7 | 
| GO:1901360 | organic cyclic compound metabolic process | 3 | 7 | 
| GO:1901362 | organic cyclic compound biosynthetic process | 4 | 7 | 
| GO:1901564 | organonitrogen compound metabolic process | 3 | 7 | 
| GO:1901566 | organonitrogen compound biosynthetic process | 4 | 7 | 
| GO:1901576 | organic substance biosynthetic process | 3 | 7 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0000166 | nucleotide binding | 3 | 7 | 
| GO:0003824 | catalytic activity | 1 | 7 | 
| GO:0004729 | oxygen-dependent protoporphyrinogen oxidase activity | 5 | 7 | 
| GO:0005488 | binding | 1 | 7 | 
| GO:0010181 | FMN binding | 4 | 7 | 
| GO:0016491 | oxidoreductase activity | 2 | 7 | 
| GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 3 | 7 | 
| GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor | 4 | 7 | 
| GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor | 4 | 7 | 
| GO:0032553 | ribonucleotide binding | 3 | 7 | 
| GO:0036094 | small molecule binding | 2 | 7 | 
| GO:0043167 | ion binding | 2 | 7 | 
| GO:0043168 | anion binding | 3 | 7 | 
| GO:0070818 | protoporphyrinogen oxidase activity | 4 | 7 | 
| GO:0070819 | menaquinone-dependent protoporphyrinogen oxidase activity | 5 | 7 | 
| GO:0097159 | organic cyclic compound binding | 2 | 7 | 
| GO:0097367 | carbohydrate derivative binding | 2 | 7 | 
| GO:1901265 | nucleoside phosphate binding | 3 | 7 | 
| GO:1901363 | heterocyclic compound binding | 2 | 7 | 
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 13 | 17 | PF00656 | 0.497 | 
| CLV_C14_Caspase3-7 | 194 | 198 | PF00656 | 0.486 | 
| CLV_C14_Caspase3-7 | 42 | 46 | PF00656 | 0.569 | 
| CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.297 | 
| CLV_NRD_NRD_1 | 171 | 173 | PF00675 | 0.486 | 
| CLV_NRD_NRD_1 | 97 | 99 | PF00675 | 0.286 | 
| CLV_PCSK_KEX2_1 | 171 | 173 | PF00082 | 0.470 | 
| CLV_PCSK_KEX2_1 | 229 | 231 | PF00082 | 0.409 | 
| CLV_PCSK_PC1ET2_1 | 229 | 231 | PF00082 | 0.382 | 
| CLV_PCSK_SKI1_1 | 112 | 116 | PF00082 | 0.297 | 
| CLV_PCSK_SKI1_1 | 56 | 60 | PF00082 | 0.263 | 
| DOC_CYCLIN_RxL_1 | 53 | 62 | PF00134 | 0.569 | 
| DOC_MAPK_gen_1 | 35 | 43 | PF00069 | 0.514 | 
| DOC_MAPK_RevD_3 | 217 | 230 | PF00069 | 0.393 | 
| DOC_PP1_SILK_1 | 197 | 202 | PF00149 | 0.476 | 
| DOC_PP2B_LxvP_1 | 182 | 185 | PF13499 | 0.405 | 
| DOC_USP7_MATH_1 | 85 | 89 | PF00917 | 0.493 | 
| DOC_WW_Pin1_4 | 118 | 123 | PF00397 | 0.427 | 
| DOC_WW_Pin1_4 | 2 | 7 | PF00397 | 0.595 | 
| LIG_14-3-3_CanoR_1 | 171 | 181 | PF00244 | 0.331 | 
| LIG_APCC_ABBAyCdc20_2 | 160 | 166 | PF00400 | 0.350 | 
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.609 | 
| LIG_BRCT_BRCA1_1 | 68 | 72 | PF00533 | 0.577 | 
| LIG_BRCT_BRCA1_1 | 87 | 91 | PF00533 | 0.355 | 
| LIG_deltaCOP1_diTrp_1 | 166 | 173 | PF00928 | 0.336 | 
| LIG_FHA_1 | 104 | 110 | PF00498 | 0.522 | 
| LIG_FHA_1 | 157 | 163 | PF00498 | 0.358 | 
| LIG_FHA_1 | 17 | 23 | PF00498 | 0.497 | 
| LIG_FHA_2 | 150 | 156 | PF00498 | 0.297 | 
| LIG_FHA_2 | 19 | 25 | PF00498 | 0.491 | 
| LIG_LIR_Gen_1 | 165 | 174 | PF02991 | 0.319 | 
| LIG_LIR_Gen_1 | 175 | 185 | PF02991 | 0.375 | 
| LIG_LIR_Gen_1 | 53 | 61 | PF02991 | 0.492 | 
| LIG_LIR_Nem_3 | 165 | 170 | PF02991 | 0.333 | 
| LIG_LIR_Nem_3 | 175 | 180 | PF02991 | 0.337 | 
| LIG_LIR_Nem_3 | 53 | 57 | PF02991 | 0.468 | 
| LIG_LIR_Nem_3 | 62 | 68 | PF02991 | 0.440 | 
| LIG_LIR_Nem_3 | 69 | 75 | PF02991 | 0.424 | 
| LIG_LIR_Nem_3 | 88 | 93 | PF02991 | 0.353 | 
| LIG_MLH1_MIPbox_1 | 87 | 91 | PF16413 | 0.471 | 
| LIG_Pex14_1 | 133 | 137 | PF04695 | 0.326 | 
| LIG_Pex14_2 | 173 | 177 | PF04695 | 0.319 | 
| LIG_Pex14_2 | 68 | 72 | PF04695 | 0.514 | 
| LIG_REV1ctd_RIR_1 | 137 | 146 | PF16727 | 0.297 | 
| LIG_RPA_C_Fungi | 167 | 179 | PF08784 | 0.280 | 
| LIG_SH2_STAP1 | 110 | 114 | PF00017 | 0.362 | 
| LIG_SH2_STAP1 | 164 | 168 | PF00017 | 0.411 | 
| LIG_SH2_STAP1 | 54 | 58 | PF00017 | 0.362 | 
| LIG_SH2_STAT3 | 75 | 78 | PF00017 | 0.464 | 
| LIG_SH2_STAT5 | 110 | 113 | PF00017 | 0.362 | 
| LIG_SH2_STAT5 | 164 | 167 | PF00017 | 0.423 | 
| LIG_SH2_STAT5 | 49 | 52 | PF00017 | 0.364 | 
| LIG_SH2_STAT5 | 75 | 78 | PF00017 | 0.303 | 
| LIG_SH3_3 | 182 | 188 | PF00018 | 0.531 | 
| LIG_SH3_3 | 190 | 196 | PF00018 | 0.672 | 
| LIG_SUMO_SIM_par_1 | 39 | 45 | PF11976 | 0.450 | 
| LIG_UBA3_1 | 144 | 150 | PF00899 | 0.286 | 
| LIG_WW_3 | 184 | 188 | PF00397 | 0.510 | 
| MOD_CDK_SPK_2 | 2 | 7 | PF00069 | 0.499 | 
| MOD_CK1_1 | 118 | 124 | PF00069 | 0.444 | 
| MOD_CK1_1 | 81 | 87 | PF00069 | 0.269 | 
| MOD_CK2_1 | 149 | 155 | PF00069 | 0.362 | 
| MOD_GlcNHglycan | 201 | 204 | PF01048 | 0.692 | 
| MOD_GlcNHglycan | 215 | 218 | PF01048 | 0.232 | 
| MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.474 | 
| MOD_GlcNHglycan | 82 | 86 | PF01048 | 0.284 | 
| MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.164 | 
| MOD_GSK3_1 | 104 | 111 | PF00069 | 0.217 | 
| MOD_GSK3_1 | 12 | 19 | PF00069 | 0.362 | 
| MOD_GSK3_1 | 149 | 156 | PF00069 | 0.310 | 
| MOD_GSK3_1 | 81 | 88 | PF00069 | 0.425 | 
| MOD_GSK3_1 | 89 | 96 | PF00069 | 0.317 | 
| MOD_N-GLC_1 | 115 | 120 | PF02516 | 0.386 | 
| MOD_N-GLC_1 | 93 | 98 | PF02516 | 0.362 | 
| MOD_NEK2_1 | 10 | 15 | PF00069 | 0.362 | 
| MOD_NEK2_1 | 115 | 120 | PF00069 | 0.326 | 
| MOD_NEK2_1 | 149 | 154 | PF00069 | 0.362 | 
| MOD_NEK2_1 | 59 | 64 | PF00069 | 0.362 | 
| MOD_Plk_1 | 115 | 121 | PF00069 | 0.347 | 
| MOD_Plk_1 | 81 | 87 | PF00069 | 0.414 | 
| MOD_Plk_4 | 18 | 24 | PF00069 | 0.354 | 
| MOD_Plk_4 | 45 | 51 | PF00069 | 0.338 | 
| MOD_ProDKin_1 | 118 | 124 | PF00069 | 0.427 | 
| MOD_ProDKin_1 | 2 | 8 | PF00069 | 0.483 | 
| MOD_SUMO_rev_2 | 32 | 36 | PF00179 | 0.393 | 
| TRG_ENDOCYTIC_2 | 137 | 140 | PF00928 | 0.362 | 
| TRG_ENDOCYTIC_2 | 54 | 57 | PF00928 | 0.362 | 
| TRG_ENDOCYTIC_2 | 65 | 68 | PF00928 | 0.362 | 
| TRG_ER_diArg_1 | 170 | 172 | PF00400 | 0.323 | 
| TRG_Pf-PMV_PEXEL_1 | 142 | 146 | PF00026 | 0.464 | 
| TRG_Pf-PMV_PEXEL_1 | 28 | 32 | PF00026 | 0.230 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N1P9Q7 | Leptomonas seymouri | 65% | 100% | 
| A0A3S5H5V3 | Leishmania donovani | 91% | 100% | 
| A4H4U0 | Leishmania braziliensis | 78% | 100% | 
| A4HT19 | Leishmania infantum | 91% | 100% | 
| E9AL08 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% | 
| P0ACB4 | Escherichia coli (strain K12) | 49% | 100% | 
| P0ACB5 | Escherichia coli O6:H1 (strain CFT073 / ATCC 700928 / UPEC) | 49% | 100% | 
| P0ACB6 | Escherichia coli O157:H7 | 49% | 100% | 
| Q4QIU7 | Leishmania major | 100% | 100% | 
| Q9L6L1 | Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) | 49% | 100% |